BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11420417)

  • 1. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
    Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
    Häfner D; Germann PG; Hauschke D
    Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of modified natural and synthetic surfactant preparations on bacterial killing by polymorphonuclear leucocytes.
    Rauprich P; Walter G; Jarstrand C; Robertson B; Herting E
    Immunobiology; 2004; 209(8):609-17. PubMed ID: 15638129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
    Palmblad M; Johansson J; Robertson B; Curstedt T
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of exogenous surfactant by pulmonary edema fluid.
    Kobayashi T; Nitta K; Ganzuka M; Inui S; Grossmann G; Robertson B
    Pediatr Res; 1991 Apr; 29(4 Pt 1):353-6. PubMed ID: 1852528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of meconium inhibition of pulmonary surfactant by ferric chloride, copper chloride, and acetic acid.
    Almaas R; Robertson B; Linderholm B; Lundberg E; Saugstad OD; Moen A
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1789-94. PubMed ID: 11069814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome.
    Salvesen B; Curstedt T; Mollnes TE; Saugstad OD
    Neonatology; 2014; 105(2):128-35. PubMed ID: 24356240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal-derived surfactants versus past and current synthetic surfactants: current status.
    Moya F; Maturana A
    Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL
    J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
    Curstedt T; Johansson J
    Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pulmonary surfactant function by meconium.
    Moses D; Holm BA; Spitale P; Liu MY; Enhorning G
    Am J Obstet Gynecol; 1991 Feb; 164(2):477-81. PubMed ID: 1992687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran reduces surfactant inhibition by meconium.
    Tashiro K; Kobayashi T; Robertson B
    Acta Paediatr; 2000 Dec; 89(12):1439-45. PubMed ID: 11195233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphology and function of pulmonary surfactant inhibited by meconium.
    Bae CW; Takahashi A; Chida S; Sasaki M
    Pediatr Res; 1998 Aug; 44(2):187-91. PubMed ID: 9702912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.